4/16
06:35 pm
bcli
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn [Yahoo! Finance]
4/16
06:30 pm
bcli
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Low
Report
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
4/11
06:09 am
bcli
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule [Yahoo! Finance]
4/11
06:00 am
bcli
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
Medium
Report
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
4/10
06:09 am
bcli
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS [Yahoo! Finance]
4/10
06:00 am
bcli
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
Medium
Report
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
4/9
06:11 am
bcli
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS [Yahoo! Finance]
High
Report
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS [Yahoo! Finance]
4/9
06:00 am
bcli
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
High
Report
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
11/14/2023
07:05 am
bcli
brainstorm cell therapeutics inc.
BEAT
Report
-0.9%
brainstorm cell therapeutics inc.
8/14/2023
07:05 am
bcli
brainstorm cell therapeutics inc.
BEAT
Report
3.7%
brainstorm cell therapeutics inc.
5/15/2023
07:05 am
bcli
brainstorm cell therapeutics inc.
BEAT
Report
-2.1%
brainstorm cell therapeutics inc.
4/17
06:02 am
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 16
Medium
Report
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 16
4/11
06:11 am
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 10
Medium
Report
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 10
4/9
06:05 am
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 09
High
Report
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 09
4/2
04:21 pm
bcli
Form 424B5 BRAINSTORM CELL THERAPEU
Low
Report
Form 424B5 BRAINSTORM CELL THERAPEU
4/2
04:16 pm
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 02
Low
Report
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 02
4/1
09:16 am
bcli
Form 10-K BRAINSTORM CELL THERAPEU For: Dec 31
High
Report
Form 10-K BRAINSTORM CELL THERAPEU For: Dec 31
4/1
08:15 am
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 01
High
Report
Form 8-K BRAINSTORM CELL THERAPEU For: Apr 01
3/13
08:58 pm
bcli
Form 4 BRAINSTORM CELL THERAPEU For: Mar 11 Filed by: Lindborg Stacy
Medium
Report
Form 4 BRAINSTORM CELL THERAPEU For: Mar 11 Filed by: Lindborg Stacy
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register